SARS-CoV-2 productively infects primary human immune system cells in vitro and in COVID-19 patients is a research paper published in Journal of Molecular Cell Biology (2022). On theSindex it has a DataRank of 0. It has been cited 64 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Fundação de Amparo à Pesquisa do Estado de São Paulo
Grant: 2014/02438-6
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Grant: 310100/2017-8
NIGMS NIH HHS
Grant: T32 GM139774
National Institutes of Health
Grant: AI163019
NIAID NIH HHS
Grant: R01 AI163019
Fundação de Amparo à Pesquisa do Estado de São Paulo
Grant: 2013/16349-2
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Grant: INCT 465539/2014-9
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Grant: 403201/2020-9
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Grant: 380849/2020-8
National Institutes of Health
Grant: 5R01AI163019-05
Mechanism and Inhibition of SARS-CoV-2 Entry
FWCI
5.70
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals